NM_007294.4:c.179A>C

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM1PM2

The NM_007294.4(BRCA1):​c.179A>C​(p.Gln60Pro) variant causes a missense change. The variant allele was found at a frequency of 0.00000125 in 1,604,960 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q60H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

BRCA1
NM_007294.4 missense

Scores

4
8
7

Clinical Significance

- - O:1

Conservation

PhyloP100: 4.35

Publications

24 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM1
In a hotspot region, there are 12 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 19 benign, 76 uncertain in NM_007294.4
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BRCA1NM_007294.4 linkc.179A>C p.Gln60Pro missense_variant Exon 4 of 23 ENST00000357654.9 NP_009225.1 P38398-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BRCA1ENST00000357654.9 linkc.179A>C p.Gln60Pro missense_variant Exon 4 of 23 1 NM_007294.4 ENSP00000350283.3 P38398-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152214
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000399
AC:
1
AN:
250812
AF XY:
0.00000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1452746
Hom.:
0
Cov.:
28
AF XY:
0.00000138
AC XY:
1
AN XY:
723084
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33280
American (AMR)
AF:
0.00
AC:
0
AN:
44664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26046
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39560
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85600
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53358
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5550
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1104670
Other (OTH)
AF:
0.0000167
AC:
1
AN:
60018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152214
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41452
American (AMR)
AF:
0.00
AC:
0
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000434
Hom.:
0

ClinVar

Significance: -
Submissions summary: Other:1
Revision: -
LINK: link

Submissions by phenotype

Breast-ovarian cancer, familial, susceptibility to, 1 Other:1
-
Brotman Baty Institute, University of Washington
Significance:not provided
Review Status:no classification provided
Collection Method:in vitro

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.28
.;T;.;.;.;.;T;.;.;T;T;T;T;.
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.83
T;T;T;T;D;T;T;D;T;T;T;T;D;D
M_CAP
Pathogenic
0.63
D
MetaRNN
Uncertain
0.69
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.64
D
MutationAssessor
Benign
0.56
N;N;N;N;.;N;.;.;.;.;.;.;.;.
PhyloP100
4.3
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.20
N;N;N;N;N;N;N;N;N;.;N;N;D;.
REVEL
Pathogenic
0.69
Sift
Benign
0.21
T;D;D;T;D;T;T;T;D;.;D;D;T;.
Sift4G
Uncertain
0.052
T;D;D;D;D;D;.;D;D;.;D;D;.;.
Polyphen
0.068, 0.99, 0.99
.;B;.;.;.;D;.;.;D;.;.;.;.;.
Vest4
0.74
MutPred
0.54
Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);.;Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);.;Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);Gain of glycosylation at Q60 (P = 0.0192);.;
MVP
0.89
MPC
0.44
ClinPred
0.44
T
GERP RS
5.2
Varity_R
0.76
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373655067; hg19: chr17-41258506; API